1Broad Institute of Harvard and Massachusetts Institute of Technology, 1 Kendall Square, Cambridge, MA 02139, USA. stacey@broad.mit.edu
Understanding common mutations in the human cancer genome is crucial for developing new cancer drugs and treatments. Advances in genomic technologies enable systematic exploration of genetic variations driving distinct human cancers.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: